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THE CAUSES OF JAUNDICE 
A. AZZOPARDI 
M.D., Ph.D., M.R.C.Path. 
(Lecturer, Department of Pathology) 
Royal Univel'sity of Malta. 
The purpose of this investigat:on was 
to determine the relart:ive frequency of the 
various causes of clinical jaundice. It was 
carried out in the period January-March 
1972 and included all cases of jaundice ad-
mitted to the medical and surg' cal wards 
of St. Luke's Hospital. Note was made, in 
the laboratory, of patients with hyper-
1st Chart 
bilirubinaemia and/or hyperbiliruhinuria. 
The clinical h:story was then reviewed and 
each patient was followed-up. 
Analysis of the findings was made as a 
Clinico-Patho,loglcal Exercise in December 
1973. The results are being -published in 
the same chart-form in wh~ch they were 
presented. 
CLINICAL DIAGNOSES IN 43 CASES OF JAUNDICE 
CLinical Diagnos's 
Infect' ous hepaUtis 
CholecystWs; cholelithiasis 
Cirrhosis, liver 
Cholestatic jaundice 
Carcinoma stomach 
Carcinoma breast 
Carcinoma ovary 
Carcinoma head of pancreas 
Carcinoma lung and 
carcinoma nasopharynx 
Acute gastrit!,s 
Chronic pancreatttis 
Heart disease 
No clinical diagnoses 
CLinicaL Dia.gnoses 
Number of 
2 
11 
11 
1 
2 
2 
1 
3 
1 
1 
1 
1 
9 
46 * 
Clinical Diagnoses 
Percentage of 
4.3% 
23.1% 
23.1% 
2.1% 
4.2% 
4.2% 
2.1% 
6.3% 
2.1% 
2.1% 
2.1% 
2.1% 
18.9% 
100.0% 
* The number of clinical diagnoses exceeds the number of cases because some cases had multiple 
pathology. 
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2nd Chart 
BASES FOR CLINICAL DIAGNO 3ES IN 43 CASES OF JAUNDICE 
CLinicaL Diagnosis 
Infectious hepatitis 
Cholecystitis; 
choleUth~asis 
Cirrhos:s liver 
Cholestatic Jaundice 
(Toxic jaund:ce) 
Carcinoma stomach 
Carc:noma breast 
Carcinoma head of 
pancreas 
Carcinoma lung; 
status post 
carcinoma, 
nasopharynx. 
Acute gastritis 
Number of 
CLinicaL D.agnoses 
2 
11 
11 
1 
2 
2 
3 
1 
1 
Bases for CLinica~ Diagnosis 
1: SB: 3.7/18.0; UB: present; 
SGPT: 59/17; SAP: 29.2/27; 
Urobilin/ogen: in excess. 
1: SB: 17; UB: present; 
SGPT: 84; SAP: 17.3; 
Urobilin/ogen: in excess. 
NONE BIOPSIED 
4: Cholecy3tectomy 
1: LaparotO'my 
5: Unco firmed 
1: Postmortem 
1: Liver function tests. ± 
2: ElectrophO'resis 
1: Biopsy 
1: Postmortem 
1: Unsupported 
5: Sugges1tive history 
On ANABOLAN for aplastic anaemia. 
1: Barium meal shows filling defect. 
1: LaparO'tomy: no hiopsy. 
No direct confirmation of cause of jaundice. 
2: Excision biopsy. 
1: Laparotomy: no biopsy. 
1: SB: 18.6; SGPT 74; 
SAP: 39.9; OrthO'rtO'lidine: 
negative; no laparotomy. 
1: SB: 15.4; SGPT: 17; 
SAP: 19.9; Orthotolidine: 
negative; nO' laparotomy. 
Carc;noma nasopharynx 1968. 
Alpha-fetoprorte;n positive. 
Liver biO'Psy: regenerat;on and necrosis. 
PostmO'rtem: carcinoma lung with metastases 
to l'ver and lymphnodes. 
Cholecysteotomy ten years before admission. 
Past history of ureteric cakuli with colics; 
epigast:r.ic pain. 
SB: 1.7; SGPT 15; SAP 30.8. 
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Chronic pancreatitis 1 
Heart disease 1 
Carcinoma ovary 
SB serum bilirubin mg/%. 
VB urinary bilirubin. 
1 
Tenderness R. hypochondr~um; 
nausea and vomiting. SB: 2.4; 
SGPT: 84; Urobili/ogen: in excess. 
Plain abdomen: no opaque calculi. 
Mitral incomp2tenc:=; pulmonary 
oedema. Enlarged, fixed 
nodular liver: SB: 2.0; 
SGOT: 36; SGPT: 17. U B: 
present; Urobilin/ ogen: in excess. 
Pre-mortem diagnosis: 
carcinoma liver. 
Postmortem diagnos:s: 
papillary serous cystadeno-carcinoma 
wtth metas:tases. 
SGPT serum glutamic phosphopyruvic acid transam'nase in LV, 
SAP serum alkaline phosphatase in K.A. V n:ts, 
Vrobilinjogen = urobilin and urobilinogen. 
± excluding the electrophoretic pattern. 
3rd Chart 
NU~IBER OF DIAGNOSES SUPPORTED BY SPECIAL INVESTIGATION 
Clinical Diagnoses 
Infectious hepatitis 
Cholecystitis; 
choleli:thiasis 
Cirrhosis, liver 
Cholestatic 
jaundice 
Carcinoma stomach 
Carcinoma breast 
Carcinoma head of 
pancreas 
Number of 
Clinical Diagnos(3 s 
2 
11 
11 
1 
2 
2 
3 
Number 
Supported 
0 
6 
5 
o 
o 
2 
o 
Type of Investigations 
4: Cholecystectomy. 
1: Laparotomy. 
1: Postmortem. 
2: Electrophoresis. 
1: Biopsy. 
1: Postmortem. 
1: Liver function test. 
Biopsy confirms 
carcinoma breast but 
not the cause of jaundice. 
43 
Carcinoma lung 1 1 Postmortem. 
Acute gastrifs 1 0 
Chronic pancreatitis 1 0 
Heart disease 1 1 
Carcinoma ovary 1 1 Postmortem. 
TOTAL 37 15 
15 40% o~ cl!nical diagnoses. 
4th Chart 
NUMBER OF DEATHS AND POSTMORTEM DIAGNOSES 
Certified Cause of Death Number of Diagnoses • 
Infectious hepatitis 
Cholecystitis; cholelithiasis 
Cirrhosis 1iver 
Cholestatic jaundice 
Carcinoma stomach 
Carcinoma breast 
Carcinoma pancreas 
CarcJnoma lung 
Acute grastritis 
Chronic pancreatitis 
Heart disease 
Carcinoma ovary 
NUMBER OF CASES: 
TOTAL No. OF POSTMORTEMS: 
TOTAL No. OF DEATHS 
43 
3 21.3% of deaths 
14 * 
CAUSE OF DEATH VERIFIED IN 6 CASES 42.6% of deaths 
1 Laparotomy 
2 Excision 1;>iopsies 
3 Postmortems 
2 
4 
2 
2 
3 
1 
1 
* Number of d;agnoses exceeds number of deaths because one cas~ had two clinical diagnoses. 
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5th Chart 
COMPARISON OF CLINICAL AND ANATOMICAL DIAGNOSES 
IN THREE AUT OPSIED CASES 
Case No. Clinical Findif!.,']s 
7 Adenocarcinoma 
cells in ascitic 
fluid. 
Clinical Diagnoses 
Malignancy: site 
unde1termined. 
Anatomical Diagnoses 
Papillary serous 
cystadenocarcinoma 
ovary. 
AFP: pos,ttive; 
SB: 6.7; 
SGPT: 22; SAP: 31. 
16 Carcinoma naso-
pharynx 1968. 
AFP: positive; 
Recurrent carcinoma 
nasopharynx with 
metasrtases. 
No residual carcinoma 
nasopharynx. Adeno-
carcinoma lung with 
metastases to liver SB: 3.2; SGPT: 20; 
SAP: 21.6. and lymphnodes. 
20 Flattening body 
second lumbar 
vertebra. 
Carcinoma head of 
pancreas. 
Cholelithiasis; 
Biliary cirrhosis. 
SB: 18.8; 
SGPT: 32; SAP: 
21.6; "Mass in 
epigastrium. " 
AFP = Alpha-fetoprotein. 
SB = serum bilirubin mg/%. 
SGPT = serum glutamic phosphopyruvic acid transaminase in LU. 
SAP = serum alkaline phosphatase in K.A. Units. 
Concluding Note 
The management of jaundice im-
proves with a better understanding of its 
aetiology. Arriving at an accurate clinical 
diagnosis is not an easy matter; in most 
cases the nature of the jaundice is imme-
diately obvious but ,the underlying lesion 
defies detec,tion. Th's is particularly true 
of obstructive jaundice because 
I) The distinction between intra-
hepatic and eXltra-hepatic ob-
struction is not always clear cut. 
Il) It is very often impossrb1e to dis-
tinguish clinically between the 
various causes of extrahepatic 
obstructive jaundice. 
Ill) Metastatic and primary neo-
plastic disease of the liver, can 
produce a s~milar clinical 
picture. 
